Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jun 20, 2024 (2 years ago)

Little Moon Essentials

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Little Moon Essentials, Crampy Belly Rub (Camphor 1.1%), Packaged as a) 4 FL OZ (118ML) glass jar, UPC Code 6 73673 88260 2, NDC 70722-260-04; b) 2 FL OZ (59ML) glass jar, UPC Code 6 73673 88204 6, NDC 70722-260-02, Little Moon Essentials LLC Dania Beach, Fl 33004

Affected NDCs 70722-0260-02 70722-0260-04

Compare with the code on your package — it is the most precise check available.

Drug: Camphor

Recalling firm
Little Moon Essentials LLC
NDC code
70722-260-04
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0572-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Camphor recalls

See all
Class II · Moderate risk

DermaSarra

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-189-08 D-0165-2026
Class I · High risk

DermaSarra

Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.

Ongoing Microbial contamination DermaRite Industries, LLC NDC 61924-189-08 D-0611-2025

Other recalls by Little Moon Essentials LLC

All 2024 recalls